Your trusted destination for CME, CPD & Medical Education across the Middle East.
Hamad Medical Corporation (HMC), Doha, Qatar
Dr. Awni Al Shurafa is a Specialist and Fellow Physician in the Department of Hematology and Medical Oncology at Hamad Medical Corporation in Doha, Qatar. He earned his Medical Doctorate (MD) and completed comprehensive internal medicine residency training prior to undertaking specialized higher subspecialty fellowship training in clinical hematology and medical oncology across major tertiary teaching hospitals in Qatar.
In his clinical practice at Hamad General Hospital and the National Center for Cancer Care and Research (NCCCR), Dr. Al Shurafa specializes in managing both classical non-malignant hematologic disorders and hematologic malignancies. His clinical domains encompass immune thrombocytopenia (ITP), chronic myeloid leukemia (CML), non-Hodgkin lymphomas, bone marrow failure syndromes, and red blood cell disorders including sickle cell disease and complex anemias.
Dr. Al Shurafa is an active clinical researcher who has co-authored over 100 peer-reviewed scientific publications, book chapters, and research abstracts appearing in leading journals such as Blood, European Journal of Haematology, Frontiers in Hematology, and Cureus. His ongoing research investigates real-world responses to tyrosine kinase inhibitor (TKI) therapies, thrombopoietin receptor agonists, hepcidin dysregulation in chronic disease anemia, and management strategies for viral complications in hematology patients.
As an active faculty speaker for MeetingMinds Experts' regional educational platforms—including the International Conference of Classical Hematology (ICCH 2026)—Dr. Al Shurafa regularly presents original research findings, leads interactive clinical case discussions, and mentors junior clinicians. His academic efforts support the advancement of evidence-based classical hematology and the standardization of patient care practices across the Middle East.
Dr. Awni Alshurafa is a physician and clinical researcher affiliated with Hamad Medical Corporation (HMC) in Doha, Qatar. His professional work focuses on hematology, the medical specialty concerned with disorders of the blood, bone marrow, and lymphatic system. His research interests include sickle cell disease, anemia, blood cancers, myeloproliferative neoplasms, and the evaluation of treatments for complex hematologic conditions.
Dr. Alshurafa has been involved in clinical research examining the presentation, diagnosis, treatment, and outcomes of blood disorders. His work includes collaborative studies with physicians and researchers in Qatar and other institutions, contributing to the growing body of medical literature on hematologic diseases in the Middle East.
His research portfolio covers a broad range of topics, including sickle cell disease complications, chronic myeloid leukemia, immune thrombocytopenia, myeloproliferative neoplasms, and uncommon bleeding disorders. Through collaborative clinical studies, systematic reviews, and case reports, he has contributed to the documentation of treatment experiences and clinical outcomes in patients with these conditions.
A significant area of his research concerns sickle cell disease, an inherited blood disorder that can cause painful crises, chronic anemia, and complications affecting multiple organs. His work in this area includes publications examining avascular necrosis, leg ulcers, treatment-related complications, and emerging therapeutic approaches.
Dr. Alshurafa has also contributed to research on chronic myeloid leukemia and other hematologic malignancies, including studies of tyrosine kinase inhibitor therapy, treatment safety, and the management of patients with additional medical conditions. His research reflects an interest in improving understanding of treatment outcomes and supporting evidence-based clinical decision-making.
Through his professional affiliation with Hamad Medical Corporation and his research collaborations, Dr. Alshurafa contributes to clinical scholarship in hematology and the development of medical knowledge relevant to patients with complex blood disorders.
Dr. Alshurafa is identified as a medical doctor. However, detailed information about his medical school, graduation year, postgraduate qualifications, and specialist certification was not sufficiently confirmed for inclusion in this profile.

MeetingMinds Experts
MeetingMinds Experts